<DOC>
	<DOCNO>NCT01836809</DOCNO>
	<brief_summary>The prevalence renal dysfunction implantation artificial heart high . The infusion exogenous B-type natriuretic peptide ( BNP ) implantation total artificial heart ( TAH ) improve renal function sustain manner . The renal protective hormone-modulating effect nesiritide may enhance ventriculectomy compare heart failure surgery leave native myocardium intact . The goal project determine renal protective effect nesiritide implantation mechanical device .</brief_summary>
	<brief_title>Nesiritide Renal Function After Total Artificial Heart</brief_title>
	<detailed_description>This randomize , double blind placebo control study take place Cardiac Surgery Intensive Care Unit , Virginia Commonwealth University ( VCU ) Hospital Center . This study enroll 20 adult patient undergone implantation circulatory support device ( 10 TAH patient , 10 Left ventricular assist device ( LVAD ) patient ) . Patients receive standard postoperative care , include anticoagulation , continuous hemodynamic monitoring arterial line central venous line hemodynamic support determine cardiac surgery clinical team . We exclude patient receive renal replacement therapy time device implantation previous solid organ transplantation order remove confound influence calcineurin inhibitor exposure renal function . Patient unable provide inform consent also exclude . Nesiritide Infusion The patient randomize ( stratified device type ) either study drug ( nesiritide 0.005 mcg/kg/min without bolus ) placebo . A fixed-dose infusion initiate 6 hour patient come cardiopulmonary bypass continue 48 hour . Laboratory Measurements Acute chronic effect nesiritide Glomerular Filtration Rate ( GFR ) Renal Plasma Flow ( RPF ) measure continuous infusion iothalamate ( IOTH ) phenylalanine hydroxylase ( PAH ) , respectively . GFR RPF measure baseline ( -3 0 hr ) 3 interval drug/placebo administration follow : 0 6 , 6 16 16 40 . Intravenous catheter place need infusion PAH IOTH time blood collection . Urine volume , creatinine , sodium excretion also measure . Neurohormones measure time point 3-6 . Plasma renin activity measure automate chemiluminescent immunoassay ( DiaSorin Liaison ) . Serum aldosterone concentration determine liquid chromatography-mass spectrometry ( Agilent , AB Sciex API 5000 ) . Serum BNP concentration measure sandwich chemiluminescent immunoassay ( Siemens Healthcare Diagnostics , ADVIA Centaur BNP immunoassay ) . Statistical Analysis Sample size determine use urine output data preliminary observation . Power calculation show total 10 patient two-treatment parallel-design study 84 percent power detect change urine output 75 mL/hr two-sided 0.05 significance level ( use standard deviation 35 mL/hr urine output ) . Thus 10 patient include device arm study.Chi-square analysis use compare discrete variable . A two tailed Student 's t-test use compare continuous variable . A repeated measure analysis variance ( ANOVA ) use compare change clinical variable laboratory measurement across time point . A P value &lt; 0.05 consider significant . For individual comparison post-hoc test perform paired t-test analysis Bonferroni correction 2 comparison thus P value &lt; 0.025 consider significant repeated measure analyse . A Student 2-tailed paired test use compare placebo active drug value individual time point .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardio-Renal Syndrome</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Implanted total artificial heart ( CardioWest ) Left ventricular assist device ( HeartMate II ) Age &gt; 18 year Previous calcineurin inhibitor ( CNI ) exposure Hemodialysis prior device implant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Total Artificial Heart</keyword>
	<keyword>Left Ventricular Assist Device</keyword>
	<keyword>Natriuretic peptide</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiorenal Syndrome</keyword>
</DOC>